Key points are not available for this paper at this time.
We recently reported that specific genetic polymorphisms, particularly polymorphisms in thymidylate synthase (TYMS) and glutathione S -transferase M1 (GSTM1) predicted the risk of relapse among children with acute lymphoblastic leukemia (ALL).11 An accompanying commentary noted surprise that the
Relling et al. (Mon,) studied this question.